信息搜索
信息关键字:泰
 

共有2177条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109]

·黄其森“复工”急盼天降白衣骑士援手泰禾集团584亿债务悬顶两年自救无进展2022-11-21 11:29:41
·贝泰妮回应:视产品品质为企业生命线贝泰妮薇诺娜高保湿修护面霜检测结果符合质量标准要求2022-11-21 10:51:59
·薇诺娜产品退货维权事件频发母公司贝泰妮“腹背受敌”遇信任危机2022-11-21 10:47:48
·【机构调研记录】华泰保兴调研广和通、伟星新材2022-11-21 10:43:28
·对A股长期回报很乐观!中泰资管姜诚:对复杂的世界保持敬畏,尽可能让惊吓变惊喜2022-11-21 8:46:54
·黄其森“消失”8个月后回归,泰禾自救之路仍漫漫2022-11-20 7:58:50
·【机构调研记录】南方基金调研鲁泰A、通行宝等3只个股(附名单)2022-11-19 21:21:38
·荣昌生物:FDA同意泰它西普在美国开展IgA肾病适应症的Ⅲ期临床试验2022-11-19 11:53:29
·芃泰发展股东中泽通增持63万股权益变动后直接持股比例为10%2022-11-18 22:44:06
·股票行情快报:威尔泰(002058)11月18日主力资金净买入421.65万元2022-11-18 22:01:48
·股票行情快报:威海广泰(002111)11月18日主力资金净卖出358.01万元2022-11-18 21:11:26
·复星医药:复必泰二价疫苗已获中国澳门特别许可进口及中国台湾地区专案输入核准分别用于当地接种2022-11-18 21:06:50
·康泰生物:新冠疫苗Ⅲ期临床试验获得关键性数据2022-11-18 19:47:25
·康泰生物:公司新冠疫苗Ⅲ期临床试验获得关键性数据2022-11-18 19:42:55
·黄其森,回归泰禾2022-11-18 18:34:21
·个人养老金代销机构名录出炉华泰、中信、广发等14家券商在列2022-11-18 18:04:59
·欧普泰北交所IPO:11月23日起询价引入南方基金、景顺长城基金等10家战投2022-11-18 18:01:10
·闻泰科技被英国政府要求剥离NWF至少86%股权公司回应:影响不大!2022-11-18 0:46:52
·闻泰科技被英国政府要求剥离NWF至少86%股权;公司回应:影响不大!2022-11-17 23:06:39
·泰瑞机器:年初至今累计收到1368.66万元与收益相关政府补助2022-11-17 20:27:07

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109]